Cravath Leads Spectranetics In €1.9B Sale To Philips
Cravath Swaine & Moore LLP aided cardiovascular medical device company The Spectranetics Corp. in its €1.9 billion ($2.16 billion) sale to Netherlands-based health technology giant Royal Philips, an effort by the...To view the full article, register now.
Already a subscriber? Click here to view full article